cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vigil Neuroscience Inc
3 own
2 watching
Current Price
$2.82
$0.07
(2.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
133.89M
52-Week High
52-Week High
11.11000
52-Week Low
52-Week Low
2.53000
Average Volume
Average Volume
0.06M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization133.89M
icon52-Week High11.11000
icon52-Week Low2.53000
iconAverage Volume0.06M
iconDividend Yield--
iconP/E Ratio--
What does the Vigil Neuroscience Inc do?
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer s disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Vigil Neuroscience Inc make?
News & Events about Vigil Neuroscience Inc.
Ticker Report
10 months ago
Curis (NASDAQ:CRIS Get Rating) and Vigil Neuroscience (NASDAQ:VIGL Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, ...
Zolmax
1 year ago
Vigil Neuroscience (NASDAQ:VIGL Get Rating) and NanoString Technologies (NASDAQ:NSTG Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc.(Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that the Company will host an adult-onset ...
Zolmax
1 year ago
Vigil Neuroscience (NASDAQ:VIGL Get Rating) had its price target hoisted by Morgan Stanley from $11.00 to $12.00 in a report published on Monday morning, MarketBeat reports. The firm currently has an equal weight rating on the stock. Other equities analysts have also issued reports about the stock. ...
Ticker Report
1 year ago
Vigil Neuroscience (NASDAQ:VIGL Get Rating) had its price target hoisted by Morgan Stanley from $11.00 to $12.00 in a report published on Monday morning, MarketBeat reports. The firm currently has an equal weight rating on the stock. Other equities analysts have also issued reports about the...
Frequently Asked Questions
Frequently Asked Questions
What is Vigil Neuroscience Inc share price today?
plus_minus_icon
Can Indians buy Vigil Neuroscience Inc shares?
plus_minus_icon
How can I buy Vigil Neuroscience Inc shares from India?
plus_minus_icon
Can Fractional shares of Vigil Neuroscience Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vigil Neuroscience Inc stocks?
plus_minus_icon
What is today’s traded volume of Vigil Neuroscience Inc?
plus_minus_icon
What is today’s market capitalisation of Vigil Neuroscience Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vigil Neuroscience Inc?
plus_minus_icon
What percentage is Vigil Neuroscience Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vigil Neuroscience Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.82
$0.07
(2.55%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00